In our study, we also confirmed that the mRNA expression levels of MMP2 was significantly upregulated in MTAP-knockdown BT20 cells but downregulated after ODC inhibitor DFMO treatment, indicating MTAP could block breast tumor angiogenesis via inhibiting the ODC-MMP2 signaling axis. This evidence concerns the gene ODC1 and breast neoplasm.